摘要
针对表皮生长因子受体(EGFR)的靶向药物明显改善了非小细胞肺癌的预后,提示明确EGFR状态至关重要。^(18)F-FDG PET/CT以无创性的双模态显像方式,在EGFR状态预测中表现出独特优势,本文对^(18)F-FDG PET/CT预测非小细胞肺癌EGFR基因突变的研究进展进行综述。
Targeted drugs against epidermal growth factor receptor(EGFR) has significantly improved the prognosis of non-small cell lung cancer, suggesting that identification of EGFR mutation status is crucial.F-FDG PET/CT has shown unique advantages in predicting EGFR status with non-invasive bimodal imaging, therefore, this article reviews the research progress ofF-FDG PET/CT in predicting EGFR status of non-small cell lung cancer in recent years.
作者
史爱琪
王建林
王育珠
郭国蓉
范丑丑
柳江燕
SHI Aiqi;WANG Jianlin;WANG Yuzhu;GUO Guorong;FAN Chouchou;LIU Jiangyan(Department of Nuclear Medicine,Lanzhou University Second Hospital,Key Laboratory of Medical Imaging of Gansu Province,Lanzhou 730030,China)
出处
《中国医学影像学杂志》
CSCD
北大核心
2022年第8期861-865,共5页
Chinese Journal of Medical Imaging
基金
甘肃省自然科学基金(21JR1RA167)
兰州大学第二医院萃英研究生指导老师培育计划(CYDSPY202001)。
